• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用CT定量参数鉴别肾上腺乏脂性腺瘤与结节性增生:一项可行性研究

Differentiate adrenal lipid-poor adenoma from nodular hyperplasia with CT quantitative parameters: a feasibility study.

作者信息

Bai Xin, Xu Lili, Zhang Xiaoxiao, Zheng Huimin, Zhang Hong, Zhang Yan, Zhang Jiahui, Chen Li, Peng Qianyu, Guo Erjia, Zhang Gumuyang, Lu Lin, Jin Zhengyu, Sun Hao

机构信息

Department of Radiology, State Key Laboratory of Complex Severe and Rare Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

Department of Radiology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.

出版信息

Abdom Radiol (NY). 2024 Oct 19. doi: 10.1007/s00261-024-04642-9.

DOI:10.1007/s00261-024-04642-9
PMID:39425754
Abstract

OBJECTIVES

To explore the potential of CT quantitative parameters in differentiating adrenal lipid-poor adenoma (LPA) from nodular hyperplasia and evaluate diagnostic performance.

MATERIALS AND METHODS

Patients with LPA or nodular hyperplasia who underwent contrast-enhanced CT before adrenalectomy were analyzed retrospectively. The study included 128 patients (83 with LPA and 45 with nodular hyperplasia). Each lesion's unenhanced attenuation, portal-venous phase attenuation (CTp), and the portal-venous phase attenuation of the abdominal aorta were evaluated. We subsequently calculated absolute enhancement [a lesion's portal-venous phase attenuation minus unenhanced attenuation (in HUs)], relative enhancement (absolute enhancement divided by unenhanced attenuation), and the relative enhancement ratio [(absolute enhancement divided by abdominal aorta's portal-venous phase attenuation) ×100%]. Lesion number and size were recorded. Volume was assessed by ITK-snap software and the ratio of lesion volume to ipsilateral adrenal volume (volume ratio) was determined. Intergroup differences were analyzed using Student's t-test and chi-squared test. Logistic regression models were developed, and receiver operating characteristic (ROC) curves were constructed to determine the area under the ROC curve (AUC), sensitivity, and specificity. The model's performance was then compared against radiologists' subjective assessments, and the inter- and intra-reader agreement values among radiologists were calculated.

RESULTS

Portal-venous phase attenuation, volume ratio, and lesion number were independent predictors of LPA. The logistic regression model incorporating CTp, volume ratio, and lesion number achieved an AUC of 0.835, with a sensitivity of 73.5% and a specificity of 80.0%. The radiologists' diagnostic specificity and accuracy appeared to be inferior to the model. The inter-reader agreement among radiologists ranged from 0.082 to 0.535, and the intra-reader agreement of two radiologists were 0.734 and 0.583.

CONCLUSION

The portal-venous phase CT demonstrated potential in distinguishing LPA from nodular hyperplasia. The diagnostic performance of the model integrating CTp, volume ratio, and lesion number outperformed radiologists in terms of variability and reproducibility.

摘要

目的

探讨CT定量参数在鉴别肾上腺乏脂性腺瘤(LPA)与结节样增生中的潜力,并评估其诊断效能。

材料与方法

回顾性分析肾上腺切除术前行增强CT检查的LPA或结节样增生患者。本研究纳入128例患者(83例LPA患者和45例结节样增生患者)。评估每个病灶的平扫衰减值、门静脉期衰减值(CTp)以及腹主动脉的门静脉期衰减值。随后我们计算了绝对强化值[病灶门静脉期衰减值减去平扫衰减值(单位为HU)]、相对强化值(绝对强化值除以平扫衰减值)以及相对强化率[(绝对强化值除以腹主动脉门静脉期衰减值)×100%]。记录病灶数量和大小。采用ITK-snap软件评估体积,并确定病灶体积与同侧肾上腺体积之比(体积比)。采用Student t检验和卡方检验分析组间差异。建立逻辑回归模型,并构建受试者操作特征(ROC)曲线以确定ROC曲线下面积(AUC)、敏感性和特异性。然后将该模型的性能与放射科医生的主观评估进行比较,并计算放射科医生之间的阅片者间一致性值和阅片者内一致性值。

结果

门静脉期衰减值、体积比和病灶数量是LPA的独立预测因素。纳入CTp、体积比和病灶数量的逻辑回归模型的AUC为0.835,敏感性为73.5%,特异性为80.0%。放射科医生的诊断特异性和准确性似乎低于该模型。放射科医生之间的阅片者间一致性范围为0.082至0.535,两名放射科医生的阅片者内一致性分别为0.734和0.583。

结论

门静脉期CT在鉴别LPA与结节样增生方面显示出潜力。整合CTp、体积比和病灶数量的模型在变异性和可重复性方面的诊断性能优于放射科医生。

相似文献

1
Differentiate adrenal lipid-poor adenoma from nodular hyperplasia with CT quantitative parameters: a feasibility study.利用CT定量参数鉴别肾上腺乏脂性腺瘤与结节性增生:一项可行性研究
Abdom Radiol (NY). 2024 Oct 19. doi: 10.1007/s00261-024-04642-9.
2
Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors.门静脉期相对增强比值对乏脂性肾上腺肿瘤的诊断价值。
Abdom Radiol (NY). 2022 Sep;47(9):3308-3317. doi: 10.1007/s00261-022-03593-3. Epub 2022 Jul 1.
3
Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.门静脉期相对增强比值在诊断乏脂性肾上腺腺瘤中的作用。
Radiology. 2021 Nov;301(2):360-368. doi: 10.1148/radiol.2021210231. Epub 2021 Aug 31.
4
Focal nodular hyperplasia and hepatocellular adenoma of the liver: differentiation with multiphasic helical CT.肝脏局灶性结节性增生与肝细胞腺瘤:多期螺旋CT鉴别诊断
AJR Am J Roentgenol. 2001 Jun;176(6):1493-8. doi: 10.2214/ajr.176.6.1761493.
5
Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.肾上腺腺瘤与转移瘤:能谱 CT 双能量虚拟平扫及碘图成像的诊断效能。
Radiology. 2020 Aug;296(2):324-332. doi: 10.1148/radiol.2020192227. Epub 2020 May 26.
6
Dual Energy-Derived Metrics for Differentiating Adrenal Adenomas From Nonadenomas on Single-Phase Contrast-Enhanced CT.基于双能量 CT 衍生指标鉴别单相增强 CT 扫描中肾上腺腺瘤与非腺瘤。
AJR Am J Roentgenol. 2023 May;220(5):693-704. doi: 10.2214/AJR.22.28323. Epub 2022 Oct 23.
7
CT-based radiomics nomogram for differentiation of adrenal hyperplasia from lipid-poor adenoma: an exploratory study.基于 CT 的影像组学列线图鉴别肾上腺增生与乏脂性腺瘤:一项探索性研究。
BMC Med Imaging. 2023 Jan 7;23(1):4. doi: 10.1186/s12880-022-00951-x.
8
Dual-phase computed tomographic angiography of focal nodular hyperplasia: defining predictable postcontrast attenuation levels relative to aorta and inferior vena cava.局灶性结节性增生的双期计算机断层血管造影:定义相对于主动脉和下腔静脉的可预测的造影剂后衰减水平。
J Comput Assist Tomogr. 2010 Sep-Oct;34(5):720-4. doi: 10.1097/RCT.0b013e3181e23af8.
9
Development and Validation of a Clinical-Image Model for Quantitatively Distinguishing Uncertain Lipid-Poor Adrenal Adenomas From Nonadenomas.一种用于定量区分不确定的低脂肾上腺腺瘤与非腺瘤的临床影像模型的开发与验证
Front Oncol. 2022 Jul 13;12:902991. doi: 10.3389/fonc.2022.902991. eCollection 2022.
10
Evaluation of relative wash-in ratio of adrenal lesions at early biphasic CT.早期双期 CT 评价肾上腺病变的相对增强率。
AJR Am J Roentgenol. 2010 Jun;194(6):1484-91. doi: 10.2214/AJR.09.3636.

本文引用的文献

1
CT-based radiomics nomogram for differentiation of adrenal hyperplasia from lipid-poor adenoma: an exploratory study.基于 CT 的影像组学列线图鉴别肾上腺增生与乏脂性腺瘤:一项探索性研究。
BMC Med Imaging. 2023 Jan 7;23(1):4. doi: 10.1186/s12880-022-00951-x.
2
Diagnostic value of the relative enhancement ratio of the portal venous phase to unenhanced CT in the identification of lipid-poor adrenal tumors.门静脉期相对增强比值对乏脂性肾上腺肿瘤的诊断价值。
Abdom Radiol (NY). 2022 Sep;47(9):3308-3317. doi: 10.1007/s00261-022-03593-3. Epub 2022 Jul 1.
3
Relative Enhancement Ratio of Portal Venous Phase to Unenhanced CT in the Diagnosis of Lipid-poor Adrenal Adenomas.
门静脉期相对增强比值在诊断乏脂性肾上腺腺瘤中的作用。
Radiology. 2021 Nov;301(2):360-368. doi: 10.1148/radiol.2021210231. Epub 2021 Aug 31.
4
Artificial intelligence for clinical oncology.人工智能在临床肿瘤学中的应用。
Cancer Cell. 2021 Jul 12;39(7):916-927. doi: 10.1016/j.ccell.2021.04.002. Epub 2021 Apr 29.
5
Adrenal Adenomas versus Metastases: Diagnostic Performance of Dual-Energy Spectral CT Virtual Noncontrast Imaging and Iodine Maps.肾上腺腺瘤与转移瘤:能谱 CT 双能量虚拟平扫及碘图成像的诊断效能。
Radiology. 2020 Aug;296(2):324-332. doi: 10.1148/radiol.2020192227. Epub 2020 May 26.
6
Adrenal cortical adenoma: current update, imaging features, atypical findings, and mimics.肾上腺皮质腺瘤:最新进展、影像学特征、非典型表现及类似疾病。
Abdom Radiol (NY). 2020 Apr;45(4):905-916. doi: 10.1007/s00261-019-02215-9.
7
Adrenocortical hyperplasia: a review of clinical presentation and imaging.肾上腺皮质增生:临床表现和影像学综述。
Abdom Radiol (NY). 2020 Apr;45(4):917-927. doi: 10.1007/s00261-019-02048-6.
8
Imaging features of adrenal masses.肾上腺肿块的影像学特征。
Insights Imaging. 2019 Jan 25;10(1):1. doi: 10.1186/s13244-019-0688-8.
9
The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results.动态对比增强 T1 加权 MRI 序列在鉴别富含脂和乏脂性肾上腺腺瘤与非腺瘤性病变中的作用:初步结果。
Abdom Radiol (NY). 2018 Aug;43(8):2119-2129. doi: 10.1007/s00261-017-1429-4.
10
Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee.偶发肾上腺肿块的管理:美国放射学会偶发发现委员会白皮书
J Am Coll Radiol. 2017 Aug;14(8):1038-1044. doi: 10.1016/j.jacr.2017.05.001. Epub 2017 Jun 23.